|
Insurance & Litigation
•
|
Tools & Information
•
•
•
|
|
 Back to Reuters Health News Archives
Reuters Health News: 01-21-2005
WASHINGTON (Reuters) - A "morning after" treatment for the AIDS virus can help prevent infection after a rape, contact with a contaminated needle or even a night of passion without a condom, U.S. health officials said on Thursday.
NEW YORK (Reuters Health) - Exposure to secondhand smoke appears to increase the risk of cervical cancer, albeit to a lesser extent than active smoking, new research shows.
NEW YORK (Reuters Health) - People who like their bananas, carrots and beets may have a lower risk of developing kidney cancer than those who turn their noses up at the foods, a large Swedish study suggests.
WASHINGTON (Reuters) - The U.S. Court of Appeals for the Federal Circuit on Friday ruled against Teva Pharmaceuticals Industries Ltd. in its bid to keep 180 days of exclusivity for its generic version of Pfizer Inc.'s popular antidepressant Zoloft.
NEW YORK (Reuters Health) - The synthetic musks that give a pleasing scent to perfumes and soaps enhance the effect of toxins on the cells of mussels -- raising the possibility, researchers say, that the same could be true in humans.
NEW YORK (Reuters Health) - Patients are usually told not to take aspirin before having a stool test to screen for colon cancer, but that recommendation seems to be unnecessary, a new study shows.
LONDON (Reuters) - Young men who perform well in intelligence tests have less risk of committing suicide than those with lower scores, Swedish scientists said on Friday.
LONDON (Reuters) - Britain's suicide rate for young men has plunged to its lowest level in two decades and is nearly 30 percent below its peak in 1998, the government announced on Friday.
FRANKFURT/JOHANNESBURG (Reuters) - The World Health Organization on Thursday gave its backing to Viramune, an anti-AIDS drug from Germany's Boehringer Ingelheim, despite a U.S regulatory warning that the medicine could cause liver damage.
NEW YORK (Reuters Health) - A technique called molecular breast imaging (MBI) is highly sensitive in detecting small lesions and can also spot tumors missed by mammography and ultrasound, researchers report.
|
|
